Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026
16/09/2026 04:29
BRIEF-EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026 Sept 16 (Reuters) - EBR Systems Inc EBR.AX:
ANNOUNCES ITS PLAN TO SUBMIT A CHANGES BEING EFFECTED (CBE) PREMARKET APPROVAL (PMA) SUPPLEMENT TO FDA IN Q4 2026
Further company coverage: EBR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026